Ecto-ADP-ribosyltransferases (ARTs): Emerging actors in cell communication and signaling

被引:100
作者
Seman, M
Adriouch, S
Haag, F
Koch-Nolte, F
机构
[1] Univ Paris 07, F-75251 Paris, France
[2] Univ Hamburg, Inst Immunol, D-20246 Hamburg, Germany
[3] Vaccine Lab, Rostock, Germany
关键词
D O I
10.2174/0929867043455611
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian ecto ADP-ribosyltransferases (ARTs) constitute a family of structurally related proteins expressed on the cell surface or secreted in the extracellular compartment. Using NAD(+) as substrate, they transfer ADP-ribose groups onto target proteins. In contrast to intracellular poly(ADP-ribosyl)transferases (PARPs), these enzymes transfer a single ADPR and are thus mono-ARTs. Five paralogs (ARTI-5) have been cloned but only four of them are expressed in human due to a defective ART2 gene, and six in the mouse as the result of ART2 gene duplication. The recent determination of the crystal structure of rat ART2 reveals homologies with bacterial ART toxins and provides a molecular basis for understanding the specificity of ARTs for their targets. A combination of different technological approaches reveals that ecto-ARTs are expressed in different tissues with privileged sites such as heart and skeletal muscles for ARTI, T lymphocytes for ART2 or testis for ART5. It also indicates that ART expression is highly regulated. ADP-ribosylation of target proteins on cell surfaces or circulating in body fluids leads to reversible post-translational modifications which can inhibit the targets, as known for bacterial ARTs, or activate them, as in the crosstalk between mouse ART2 and the cytolytic P2X7 receptor on T lymphocytes. ART activity in the extracellular compartment provides sophisticated regulatory mechanisms for cell communication. This designates ecto-ARTs as new candidates for drug targeting.
引用
收藏
页码:857 / 872
页数:16
相关论文
共 161 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]  
Ablamunits V, 2001, DIABETOLOGIA, V44, P848
[3]   Cutting edge: A natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor [J].
Adriouch, S ;
Dox, C ;
Welge, V ;
Seman, M ;
Koch-Nolte, F ;
Haag, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (08) :4108-4112
[4]   Rapid induction of naive T cell apoptosis by ecto-nicotinamide adenine dinucleotide: Requirement for mono(ADP-ribosyl)Transferase 2 and a downstream effector [J].
Adriouch, S ;
Ohlrogge, W ;
Haag, F ;
Koch-Nolte, F ;
Seman, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :196-203
[5]   Molecular control of neutrophil apoptosis [J].
Akgul, C ;
Moulding, DA ;
Edwards, SW .
FEBS LETTERS, 2001, 487 (03) :318-322
[6]  
AKTORIES K, 1991, ADP RIBOSYLATING TOX
[7]  
AKTORIES K, 2000, BACTERIAL PROTEIN TO
[8]   A possible role for mono(ADP-ribosyl)transferase in the signalling pathway mediating neutrophil chemotaxis [J].
Allport, JR ;
Donnelly, LE ;
Kefalas, P ;
Lo, G ;
Nunn, A ;
YadollahiFarsani, M ;
Rendell, NB ;
Murray, S ;
Taylor, GW ;
MacDermot, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (01) :99-106
[9]   Reduction by inhibitors of mono(ADP-ribosyl)transferase of chemotaxis in human neutrophil leucocytes by inhibition of the assembly of filamentous actin [J].
Allport, JR ;
Donnelly, LE ;
Hayes, BP ;
Murray, S ;
Rendell, NB ;
Ray, KP ;
MacDermot, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (05) :1111-1118
[10]  
ALTHAUS FR, 1985, ADP RIBOSYLATION PRO